These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Recent findings on catecholamine receptors]. Inaba M; Nakamura M Nihon Rinsho; 1981 Sep; 39(9):3027-30. PubMed ID: 6279932 [No Abstract] [Full Text] [Related]
3. Further investigation on adrenergic alpha- and beta-receptors in the isolated rabbit myocardium. Hayashi A; Nakanishi H; Fujinami K; Ono Y Fukushima J Med Sci; 1978 Feb; 25(1-2):15-22. PubMed ID: 218875 [No Abstract] [Full Text] [Related]
4. Monoclonal antibodies and autoantibodies in the isolation and characterization of neurotransmitter receptors: the future of receptor research. Venter JC J Mol Cell Cardiol; 1982 Dec; 14(12):687-93. PubMed ID: 6187930 [No Abstract] [Full Text] [Related]
5. Receptors and the mechanism of action of ECT. Lerer B; Belmaker RH Biol Psychiatry; 1982 Apr; 17(4):497-511. PubMed ID: 6282347 [No Abstract] [Full Text] [Related]
9. [Regulatory effects of the presynaptic receptors on transmitter release (author's transl)]. Yang K Sheng Li Ke Xue Jin Zhan; 1982 Jan; 13(1):43-7. PubMed ID: 6125032 [No Abstract] [Full Text] [Related]
10. [Piracetam and the activity of alpha- and beta-adrenergic, dopaminergic and muscarine cholinergic receptors (author's transl)]. Atanacković D; Simonić A Lijec Vjesn; 1981 Dec; 103(12):545-9. PubMed ID: 6285100 [No Abstract] [Full Text] [Related]
11. Neural pathways and neurotransmitters affecting melatonin synthesis. Ebadi M; Govitrapong P J Neural Transm Suppl; 1986; 21():125-55. PubMed ID: 2875124 [TBL] [Abstract][Full Text] [Related]
12. Separation of solubilized alpha and beta adrenergic receptors by affinity chromatography. Wood CL; Caron MG; Lefkowitz RJ Biochem Biophys Res Commun; 1979 May; 88(1):1-8. PubMed ID: 222278 [No Abstract] [Full Text] [Related]
13. Investigations on the binding properties of the nootropic agent pyroglutamic acid. Barone D; Spignoli G Drugs Exp Clin Res; 1990; 16(2):85-99. PubMed ID: 1976055 [TBL] [Abstract][Full Text] [Related]
14. On the mode of action of mianserin. Leonard BE Adv Biochem Psychopharmacol; 1982; 31():301-19. PubMed ID: 6282060 [No Abstract] [Full Text] [Related]
15. Interaction of catecholamine-derived alkaloids with central neurotransmitter receptors. Nimit Y; Schulze I; Cashaw JL; Ruchirawat S; Davis VE J Neurosci Res; 1983; 10(2):175-89. PubMed ID: 6313954 [TBL] [Abstract][Full Text] [Related]
16. The pharmacology of antidepressants at the synapse: focus on newer compounds. Richelson E J Clin Psychiatry; 1994 Sep; 55 Suppl A():34-9; discussion 40-1, 98-100. PubMed ID: 7961541 [TBL] [Abstract][Full Text] [Related]
17. A role of some central neurotransmitter systems in the mechanism of electroconvulsive shock action. Kleinrok Z; Wielosz M Pol J Pharmacol Pharm; 1985; 37(6):745-52. PubMed ID: 3008135 [TBL] [Abstract][Full Text] [Related]
18. Drug and transmitter receptors in human brain. Characterization and localization of serotonin, dopamine and adrenergic receptors. Maloteaux JM Acta Neurol Belg; 1986; 86(2):61-129. PubMed ID: 2873704 [TBL] [Abstract][Full Text] [Related]